Washington, D.C. – The American Clinical Laboratory Association’s (ACLA) President, Susan Van Meter, issued the following statement after the House Energy and Commerce Committee’s Health ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement after the U.S. Food and Drug Administration (FDA) released a proposed ... Read More
September 7, 2023 update: Based on discussions with ACLA and other key stakeholders, CMS has made the decision to withdraw the policy change referenced in the ... Read More
June is Men’s Health Month, an opportunity to focus on the many ways that recommended clinical laboratory testing is essential in assessing, addressing and managing ... Read More
Washington, D.C. – The American Clinical Laboratory Association has joined with more than 30 health care provider organizations to urge House and Senate leadership to protect ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement as the federal government’s formal declaration of a Public Health Emergency (PHE) ... Read More
May is Women’s Health Month – a perfect opportunity to focus on the value clinical laboratories bring to supporting women and their clinicians in evaluating ... Read More
The below blog was written by ACLA President Susan Van Meter. The American Clinical Laboratory Association (ACLA) is grateful to represent the nation’s leading clinical ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) released the following statement in response to the Biden-Harris Administration designating fentanyl-xylazine as an emerging threat: “The ... Read More
